Cargando…

Paediatric outpatient prescriptions in France between 2010 and 2019: A nationwide population-based study: Paediatric outpatient prescriptions in France, 2010 to 2019

BACKGROUND: Paediatric outpatient prescription (POP) monitoring is pivotal to identify inadequate prescriptions and optimize drug use. We aimed at describing recent trends in POPs in France. METHODS: All reimbursed dispensations of outpatient prescribed drugs (excluding vaccines) were prospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taine, Marion, Offredo, Lucile, Dray-Spira, Rosemary, Weill, Alain, Chalumeau, Martin, Zureik, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454786/ https://www.ncbi.nlm.nih.gov/pubmed/34557839 http://dx.doi.org/10.1016/j.lanepe.2021.100129

Ejemplares similares

Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century: A Systematic Review
por: Taine, Marion, et al.
Publicado: (2022)

Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020
por: Taine, Marion, et al.
Publicado: (2021)

Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023)

Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France
por: Roland, Noémie, et al.
Publicado: (2021)

Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study
por: Roland, Noémie, et al.
Publicado: (2022)

Colonoscopy in France during the COVID-19 pandemic
por: Meyer, Antoine, et al.
Publicado: (2021)

Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
por: Billioti de Gage, Sophie, et al.
Publicado: (2020)

Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France
por: Roland, Noémie, et al.
Publicado: (2022)

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
por: Zureik, Mahmoud, et al.
Publicado: (2023)

Antibiotic prescription preferences in paediatric outpatient setting in Estonia and Sweden
por: Lass, Jana, et al.
Publicado: (2013)

Diminution drastique des mises en route de biomédicaments chez les patients atteints de psoriasis durant la pandémie de COVID-19 en France
por: Penso, Laetitia, et al.
Publicado: (2021)

Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France
por: Coste, Joël, et al.
Publicado: (2020)

Traitements du psoriasis et risque d’hospitalisation ou de décès pour COVID-19. Étude de cohorte à propos de 132 6312 patients atteints de psoriasis en France
por: Penso, Laetitia, et al.
Publicado: (2021)

Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care – a nationwide study
por: Olsson, J, et al.
Publicado: (2011)

Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France
por: Chaignot, Christophe, et al.
Publicado: (2018)

Marked reductions in outpatient antibiotic prescriptions for children and adolescents – a population-based study covering 83% of the paediatric population, Germany, 2010 to 2018
por: Holstiege, Jakob, et al.
Publicado: (2020)

No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease
por: Botton, Jérémie, et al.
Publicado: (2022)

Outpatient Antibiotic Prescriptions in France: Patients and Providers Characteristics and Impact of the COVID-19 Pandemic
por: BARA, Wilfried, et al.
Publicado: (2022)

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
por: Semenzato, Laura, et al.
Publicado: (2021)

A Survey of Prescription Errors in Paediatric Outpatients in Multi-Primary Care Settings: The Implementation of an Electronic Pre-Prescription System
por: Tan, Lu, et al.
Publicado: (2022)

Large increase of vertebral osteomyelitis in France: a 2010–2019 cross-sectional study
por: Conan, Yoann, et al.
Publicado: (2021)

Utilisation des données du Système national des données de santé et/ou PMSI pour des études en lien avec la COVID-19 en France: bilan des publications scientifiques indexées dans Medline
por: Weill, A., et al.
Publicado: (2023)

Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
por: Laanani, Moussa, et al.
Publicado: (2023)

Epidemiology of Lyme Borreliosis in France in Primary Care and Hospital Settings, 2010–2019
por: Nuttens, Charles, et al.
Publicado: (2023)

Antidepressants overuse in primary care: prescription trends between 2010-2019 in Catalonia
por: Gonzalez, M. S., et al.
Publicado: (2023)

Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
por: Buehrle, Deanna J, et al.
Publicado: (2020)

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France
por: Semenzato, Laura, et al.
Publicado: (2022)

Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France
por: Jabagi, Marie Joelle, et al.
Publicado: (2019)

Impact de l’épidémie COVID-19 sur l'utilisation des contraceptifs en France en 2020 et jusqu'en avril 2021
por: Roland, N., et al.
Publicado: (2022)

Trends in Outpatient Telemedicine Utilization Among Rural Medicare Beneficiaries, 2010 to 2019
por: Barnett, Michael L., et al.
Publicado: (2021)

Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France
por: Blotière, Pierre‐Olivier, et al.
Publicado: (2018)

Trends in prescription of anti-seizure medicines for Japanese pediatric outpatients during 2013–2019
por: Kikuchi, Daisuke, et al.
Publicado: (2021)

Prescription opioids and economic hardship in France
por: Natali, Ilaria, et al.
Publicado: (2023)

Antibiotic prescription in the outpatient paediatric population attending emergency departments in Lombardy, Italy: a retrospective database review
por: Messina, Francesco, et al.
Publicado: (2019)

Short‐Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient Care
por: Bouillon, Kim, et al.
Publicado: (2016)

Antiviral treatment in outpatients with herps zoster in six major areas of China, 2010–2019
por: Yu, Zhenwei, et al.
Publicado: (2022)

Space-time distribution of urinary incontinence outpatient production in men, Brazil, 2010-2019
por: Nicolato, Fernanda Vieira, et al.
Publicado: (2022)

Determinants of Growth in Prescription Drug Spending Using 2010–2019 Health Insurance Claims Data
por: Lee, HyeYeong, et al.
Publicado: (2021)

Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems
por: Blotière, Pierre-Olivier, et al.
Publicado: (2021)

Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021
por: Billioti de Gage, Sophie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qcr62tlt9bvufc8vmocv6bfjkf